A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function



Status:Archived
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2009
End Date:October 2010

Use our guide to learn which trials are right for you!

Evaluation of Bladder Function in Relapsing Remitting Multiple Sclerosis Patients Treated With Natalizumab (TYSABRI)


A recent report has demonstrated improvements in QoL parameters in patients receiving
TYSABRI® (Rudick et al, 2007). This observation, coupled with anecdotal reports and our own
experience, lead us to hypothesize that TYSABRI® will have a demonstrable beneficial effect
on improving patient's bladder function as defined by changes in baseline to month 6 scores
on the UDI-6 and also on patient reported incontinence episodes and micturitions per day.



We found this trial at
2
sites
Milwaukee, Wisconsin 53215
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Salt Lake City, Utah 84103
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials